Case report finds endoxifen improves symptoms in schizoaffective disorder, suggesting novel treatment options.
Schizoaffective disorder shares symptomatology and pathophysiology with schizophrenia and bipolar disorder. Studies related to treatment option and their efficacy in schizoaffective disorder are limited; thus, no current consensus treatment guidelines exist. Patients with schizoaffective disorders are treated mainly with combination of antipsychotics and mood stabilizers or antidepressants. Here, the author presents a case of schizoaffective disorders that was successfully treated with endoxifen, which had efficacy issues with amisulpride, quetiapine, and risoperidone and safety issues with clozapine.
No takes yet. Share an insight, caveat, or question.
Shvetha Chilukuri (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: